Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Senior Specialist 401k Recordkeeping

T Bank N.A.
(Dallas TX)

T Bank N.A. logo

Client Service Manager

July Business Services
(Remote)

July Business Services logo

TPA Retirement Plan Consultant

EPIC RPS (TPA/DPS)
(Remote)

EPIC RPS (TPA/DPS) logo

Retirement Plan Consultant

Great Lakes Pension Associates, Inc.
(Remote)

Great Lakes Pension Associates, Inc. logo

RP-Client Service Associate

Greenline Wealth Management
(FL / Hybrid)

Greenline Wealth Management logo

Retirement Plan Consultant

July Business Services
(Remote)

July Business Services logo

Retirement Account Manager

Fringe Benefit Group
(Remote / Austin TX)

Fringe Benefit Group logo

Compliance Officer

New York City District Council of Carpenters Benefit Funds
(New York NY)

New York City District Council of Carpenters Benefit Funds logo

Retirement Plan Administrator

Retirement Solutions Specialists
(Remote / Jacksonville FL / Hybrid)

Retirement Solutions Specialists logo

Defined Contribution Account Manager

Nova 401(k) Associates
(Remote)

Nova 401(k) Associates logo

Regional Sales Director (West)

July Business Services
(CA)

July Business Services logo

Combo Plan Administrator

Pollard & Associates
(Remote)

Pollard & Associates logo

Senior Plan Administrator

Retirement Planners and Administrators (RPA)
(Remote)

Retirement Planners and Administrators (RPA) logo

Defined Contributions Compliance Consultant

Loren D. Stark Company (LDSCO)
(Remote)

Loren D. Stark Company (LDSCO) logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon

GAO Testimony: Trends in FDA's Oversight of Direct-to-Consumer Advertising of Prescription Drugs
U.S. Government Accountability Office [GAO] Link to more items from this source
May 9, 2008
19 pages. "GAO was asked to discuss trends in FDA's oversight of DTC advertising and the actions FDA has taken when it identifies violations. This statement is based on GAO's 2006 report, Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising, GAO-07-54 (November 16, 2006). In this statement, GAO discusses the [1] DTC advertising materials FDA reviews, [2] FDA's process for issuing regulatory letters citing DTC advertising materials and the number of letters issued, and [3] the effectiveness of FDA's regulatory letters at limiting the dissemination of false or misleading DTC advertising." [GAO-08-758T, May 8, 2008]

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).
© 2024 BenefitsLink.com, Inc.